Alx Oncology Holdings Inc. (ALXO)
NASDAQ · Healthcare
Alx Oncology Holdings Inc. Shareholder Equity 2018–2022
Alx Oncology Holdings Inc. annual/quarterly shareholder equity history from 2019 to 2022. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Alx Oncology Holdings Inc. shareholder equity for the quarter ending December 31, 2022 were 263.5M, a 27.43% decrease year-over-year.
- Alx Oncology Holdings Inc. shareholder equity for 2022 were 263.5M, a 27.43% decrease from 2021.
- Alx Oncology Holdings Inc. shareholder equity for 2021 were 363.0M, a 15.54% decrease from 2020.
- Alx Oncology Holdings Inc. shareholder equity for 2020 were 429.8M, a 708.51% decrease from 2019.
- Alx Oncology Holdings Inc. shareholder equity for 2019 were -70.6M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Alx Oncology Holdings Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2022 | $263 |
| 2021 | $363 |
| 2020 | $430 |
| 2019 | $-71 |
| Alx Oncology Holdings Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2022-12-31 | $263 |
| 2021-12-31 | $363 |
| 2020-12-31 | $430 |
| 2019-12-31 | $-71 |
Alx Oncology Holdings Inc. Shareholder Equity — FAQ
Alx Oncology Holdings Inc. (ALXO) shareholder equity over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALXO's shareholder equity history?
The chart and table above show Alx Oncology Holdings Inc.'s shareholder equity by year and by quarter, including the growth rate.